Forrest Innovations

Company Overview

Snapshot

Founded in July 2013 by Nitzan Paldi, Forrest Innovations operates with 1–10 employees. The company has secured $1 million in total capital across two funding rounds. In December 2015, the company received a grant from the BIRD Foundation.

Business overview

Forrest Innovations specializes in health tech and life sciences, focusing on the prevention of mosquito-borne diseases. The company implements its Natural Vector Control (NVC) solution, which utilizes a naturally occurring mechanism (RNAi) to produce sterile non-GM male mosquitoes. These mosquitoes are then released en masse via aerial deployment to compete with wild populations, aiming to suppress disease-transmitting mosquito populations. Forrest Innovations serves markets in the Americas, including Brazil, and Southeast Asia, operating within the biotechnology, pest control, and public health sectors.

Strategic signal

In November 2019, research published on medRxiv.org highlighted the successful suppression of an Aedes aegypti mosquito population using Forrest Innovations' novel biological vector control strategy. This suppression was associated with a significantly lower incidence of dengue fever in treated areas, demonstrating the efficacy of the company's NVC solution in preventing disease outbreaks. This signals strong validation for Forrest Innovations' technology and its potential to impact global public health efforts against mosquito-borne illnesses.

Company Intelligence Q&A

What is Forrest Innovations' core technology for mosquito control?

Forrest Innovations utilizes its Natural Vector Control (NVC) solution, which harnesses a naturally occurring RNAi mechanism to produce sterile non-GM male mosquitoes. These are then released to compete with wild mosquito populations, aiming to suppress disease transmission.

What was a key outcome of Forrest Innovations' project in Brazil?

Forrest Innovations successfully suppressed the disease-transmitting mosquito population in Brazil, which prevented a dengue fever outbreak in the treated neighborhoods. Untreated regions experienced rampant dengue.

When did Forrest Innovations receive a grant, and from whom?

In December 2015, Forrest Innovations received a grant from the BIRD Foundation.

What was a significant finding from the research published in November 2019?

Research published in November 2019 indicated that the successful suppression of an Aedes aegypti mosquito population using Forrest Innovations' biological vector control strategy was associated with a significantly lower incidence of dengue.

Which countries or regions does Forrest Innovations target with its solutions?

Forrest Innovations targets geomarkets including Africa, Brazil, Southeast Asia, South America, the Americas, Central America, and the United States.